Skip to main content

Manufacturing

The past 25 years have seen a steady progression in business relationships between CDMOs and drug developers.

The initial focus of identifying supply chain inefficiencies has advanced from controlling fixed costs and capacity fluctuations to gaining access to specific technologies, skills, and/or scientific expertise not possessed in-house.

Our research helps drug innovators understand the dynamic drug manufacturing environment, identify the right type of outsourcing model to best meet their organizations’ needs, and make smarter CDMO selection decisions based on hard data collected from outsourcing peers.

CDMOs benefit from understanding the competitive landscape, outsourcing drivers, CDMO selection criteria, and the decision-making process. Additionally, our reports provide insight into potential changes in demand for CDMO services and ways service providers could better meet the needs of drug developers.

manufacturing category

Major Topics:

  • Biologics
  • Bioprocessing
  • Cell & Gene Therapies
  • Clinical Manufacturing
  • Logistics
  • Oral Dosage Forms
  • Small Molecules
  • Sterile Injectables

Types of Manufacturing Reports

Market Outlook

Outsourcing Models

Service Provider Performance

Recent Manufacturing Reports

2023 Cell Therapy CDMO Benchmarking

2023 Cell Therapy CDMO Benchmarking

Read Report
Oral Dosage Forms Market Outlook (5th Ed.)

Oral Dosage Forms Market Outlook (5th Ed.)

Read Report
2023 Gene Therapy CDMO Benchmarking

2023 Gene Therapy CDMO Benchmarking

Read Report
The CMC Function at Emerging Pharma

The CMC Function at Emerging Pharma

Read Report

Interested in more of our manufacturing market research?

View Library

Industry Articles – Manufacturing